Hong Kong has lowered the age limit for China’s Sinovac vaccine from 18 to 3 years old, as the regime in Beijing pursues a zero-COVID-19 policy and a broader vaccination campaign. “Adolescents aged 12 to 17 will be accorded priority to receive the [Sinovac-]CoronaVac vaccine, with a view to extending to children of a younger age group at a later stage,”  Sophia Chan, the secretary of Hong Kong’s Food and Health, said in a statement on Saturday. China-based Sinovac Biotech earlier applied to lower the age limit for receiving its vaccine to 3 years old in the city, according to a Hong Kong government release. The extension of eligibility won the support of Hong Kong medical experts advising a government panel—citing the “good safety” of Chinese-made shots on the younger age group—in a Nov. 15 meeting, the statement said. The conclusion refers to overseas clinical trials and data from mainland China. …